Last Price
10.74
Today's Change
-1.07 (9.06%)
Day's Change
10.51 - 12.05
Trading Volume
102,346
Market Cap
14 Million
Shares Outstanding
1 Million
Avg Volume
2,650,948
Avg Price (50 Days)
4.87
Avg Price (200 Days)
5.43
PE Ratio
-1.73
EPS
-6.32
Earnings Announcement
26-Feb-2025
Previous Close
11.81
Open
11.80
Day's Range
10.5 - 12.0499
Year Range
1.62 - 29.28
Trading Volume
102,346
1 Day Change
-7.37%
5 Day Change
-12.48%
1 Month Change
363.56%
3 Month Change
154.42%
6 Month Change
149.77%
Ytd Change
335.86%
1 Year Change
4.39%
3 Year Change
-93.08%
5 Year Change
-97.38%
10 Year Change
-97.38%
Max Change
-97.38%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.